Skip to main content

Advertisement

SpringerLink
Log in

Updates on Imaging of Liver Tumors

  • Gastrointestinal Cancers (J Meyer, Section Editor)
  • Published:
Current Oncology Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

We review advances in imaging of liver tumors, by particularly focusing on the utility of novel imaging in diagnosis and management of these lesions.

Recent Findings

Contrast-enhanced CT and/or MRI are currently utilized for accurate diagnosis of liver tumors, but several ongoing studies are examining the use of other advanced techniques. Novel CT (i.e., dual-energy CT and perfusion CT), MRI (diffusion-weighted imaging, MR elastography, and T1 mapping), and image processing (texture analysis and artificial intelligence–based methods) techniques have emerged and can be used for precise characterization of liver tumors, quantification of treatment responses, and prediction of overall survival rate of patients.

Summary

Recent advancements in imaging of liver tumors allowed for a precise assessment of tumor features. These evolving technologies can be utilized for applying individualized treatment based on the presence of specific imaging biomarkers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Tang A, Hallouch O, Chernyak V, Kamaya A, Sirlin CB. Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis. Abdom Radiol (NY). 2018;43(1):13–25. https://doi.org/10.1007/s00261-017-1209-1.

    Article  PubMed  Google Scholar 

  2. Riihimäki M, Hemminki A, Sundquist K, Sundquist J, Hemminki K. The epidemiology of metastases in neuroendocrine tumors. Int J Cancer. 2016;139(12):2679–86. https://doi.org/10.1002/ijc.30400.

    Article  CAS  PubMed  Google Scholar 

  3. Tsui WM, Mori T, Liver IM, Tumor I. Benign tumors and tumor-like lesions. Diagnosis of Liver Disease: Springer. 2019:211–33. https://doi.org/10.1007/978-981-13-6806-6_16.

    Chapter  Google Scholar 

  4. Marrero JA, Kulik LM, Sirlin CB, Zhu AX, Finn RS, Abecassis MM, et al. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology. 2018;68(2):723–50. https://doi.org/10.1002/hep.29913.

    Article  PubMed  Google Scholar 

  5. Alexander W. European Association for the Study of the Liver The International Liver Congress 2019. P T. 2019;44(6):365–9.

    PubMed  PubMed Central  Google Scholar 

  6. Aube C, Oberti F, Lonjon J, Pageaux G, Seror O, N'Kontchou G, et al. EASL and AASLD recommendations for the diagnosis of HCC to the test of daily practice. Liver Int. 2017;37(10):1515–25. https://doi.org/10.1111/liv.13429.

    Article  PubMed  Google Scholar 

  7. Choi SH, Lee SS, Park SH, Kim KM, Yu E, Park Y, et al. LI-RADS classification and prognosis of primary liver cancers at gadoxetic acid-enhanced MRI. Radiology. 2019;290(2):388–97. https://doi.org/10.1148/radiol.2018181290.

    Article  PubMed  Google Scholar 

  8. Gervais DA. LI-RADS treatment response algorithm: performance and diagnostic accuracy. Radiology. 2019;292(1):235–6. https://doi.org/10.1148/radiol.2019190768.

    Article  PubMed  Google Scholar 

  9. Covey AM, Hussain S. Liver-directed therapy for hepatocellular carcinoma: an overview of techniques, outcomes, and posttreatment imaging findings. AJR Am J Roentgenol. 2017;209(1):67–76. https://doi.org/10.2214/AJR.17.17799.

    Article  PubMed  Google Scholar 

  10. Fraum TJ, Tsai R, Rohe E, Ludwig DR, Salter A, Nalbantoglu I, et al. Differentiation of hepatocellular carcinoma from other hepatic malignancies in patients at risk: diagnostic performance of the liver imaging reporting and data system version 2014. Radiology. 2018;286(1):158–72. https://doi.org/10.1148/radiol.2017170114.

    Article  PubMed  Google Scholar 

  11. Horowitz JM, Kamel IR, Arif-Tiwari H, Asrani SK, Hindman NM, Kaur H, et al. ACR appropriateness criteria chronic liver disease. J Am Coll Radiol. 2017;14(11s):391–405. https://doi.org/10.1016/j.jacr.2017.08.045.

    Article  Google Scholar 

  12. Lee YJ, Lee JM, Lee JS, Lee HY, Park BH, Kim YH, et al. Hepatocellular carcinoma: diagnostic performance of multidetector CT and MR imaging-a systematic review and meta-analysis. Radiology. 2015;275(1):97–109. https://doi.org/10.1148/radiol.14140690.

    Article  PubMed  Google Scholar 

  13. Guo J, Seo Y, Ren S, Hong S, Lee D, Kim S, et al. Diagnostic performance of contrast-enhanced multidetector computed tomography and gadoxetic acid disodium-enhanced magnetic resonance imaging in detecting hepatocellular carcinoma: direct comparison and a meta-analysis. Abdom Radiol (NY). 2016;41(10):1960–72. https://doi.org/10.1007/s00261-016-0807-7.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Chen L, Zhang L, Bao J, Zhang J, Li C, Xia Y, et al. Comparison of MRI with liver-specific contrast agents and multidetector row CT for the detection of hepatocellular carcinoma: a meta-analysis of 15 direct comparative studies. Gut. 2013;62(10):1520–1. https://doi.org/10.1136/gutjnl-2013-305231.

    Article  PubMed  Google Scholar 

  15. De Cecco CN, Caruso D, Schoepf UJ, De Santis D, Muscogiuri G, Albrecht MH, et al. A noise-optimized virtual monoenergetic reconstruction algorithm improves the diagnostic accuracy of late hepatic arterial phase dual-energy CT for the detection of hypervascular liver lesions. Eur Radiol. 2018;28(8):3393–404. https://doi.org/10.1007/s00330-018-5313-6.

    Article  PubMed  Google Scholar 

  16. Marin D, Ramirez-Giraldo JC, Gupta S, Fu W, Stinnett SS, Mileto A, et al. Effect of a noise-optimized second-generation monoenergetic algorithm on image noise and conspicuity of hypervascular liver tumors: an in vitro and in vivo study. AJR Am J Roentgenol. 2016;206(6):1222–32. https://doi.org/10.2214/ajr.15.15512.

    Article  PubMed  Google Scholar 

  17. Nagayama Y, Nakaura T, Oda S, Utsunomiya D, Funama Y, Iyama Y, et al. Dual-layer DECT for multiphasic hepatic CT with 50 percent iodine load: a matched-pair comparison with a 120 kVp protocol. Eur Radiol. 2018;28(4):1719–30. https://doi.org/10.1007/s00330-017-5114-3.

    Article  PubMed  Google Scholar 

  18. •• Lv P, Zhou Z, Liu J, Chai Y, Zhao H, Guo H, et al. Can virtual monochromatic images from dual-energy CT replace low-kVp images for abdominal contrast-enhanced CT in small- and medium-sized patients? Eur Radiol. 2019;29(6):2878–89. https://doi.org/10.1007/s00330-018-5850-zThis study compared the image quality of low-peak kilovoltage CT, DECT with automatic spectral imaging protocol selection, and 40- to 60-keV virtual monochromatic images (VMIs) in four groups of matched patients. The investigators demonstrated that VMIs at 50 keV provides similar/higher image quality when compared to matched conventional low-peak kilovoltage CT images.

    Article  PubMed  Google Scholar 

  19. Muenzel D, Lo GC, Yu HS, Parakh A, Patino M, Kambadakone A, et al. Material density iodine images in dual-energy CT: detection and characterization of hypervascular liver lesions compared to magnetic resonance imaging. Eur J Radiol. 2017;95:300–6. https://doi.org/10.1016/j.ejrad.2017.08.035.

    Article  PubMed  Google Scholar 

  20. Kaltenbach B, Wichmann JL, Pfeifer S, Albrecht MH, Booz C, Lenga L, et al. Iodine quantification to distinguish hepatic neuroendocrine tumor metastasis from hepatocellular carcinoma at dual-source dual-energy liver CT. Eur J Radiol. 2018;105:20–4. https://doi.org/10.1016/j.ejrad.2018.05.019.

    Article  PubMed  Google Scholar 

  21. Anzidei M, Di Martino M, Sacconi B, Saba L, Boni F, Zaccagna F, et al. Evaluation of image quality, radiation dose and diagnostic performance of dual-energy CT datasets in patients with hepatocellular carcinoma. Clin Radiol. 2015;70(9):966–73. https://doi.org/10.1016/j.crad.2015.05.003.

    Article  CAS  PubMed  Google Scholar 

  22. Mahmood U, Horvat N, Horvat JV, Ryan D, Gao Y, Carollo G, et al. Rapid switching kVp dual energy CT: value of reconstructed dual energy CT images and organ dose assessment in multiphasic liver CT exams. Eur J Radiol. 2018;102:102–8. https://doi.org/10.1016/j.ejrad.2018.02.022.

    Article  PubMed  PubMed Central  Google Scholar 

  23. De Cecco CN, Darnell A, Rengo M, Muscogiuri G, Bellini D, Ayuso C, et al. Dual-energy CT: oncologic applications. AJR Am J Roentgenol. 2012;199(5 Suppl):S98–s105. https://doi.org/10.2214/ajr.12.9207.

    Article  PubMed  Google Scholar 

  24. Jiang T, Zhu AX, Sahani DV. Established and novel imaging biomarkers for assessing response to therapy in hepatocellular carcinoma. J Hepatol. 2013;58(1):169–77. https://doi.org/10.1016/j.jhep.2012.08.022.

    Article  CAS  PubMed  Google Scholar 

  25. Marin D, Nelson RC, Barnhart H, Schindera ST, Ho LM, Jaffe TA, et al. Detection of pancreatic tumors, image quality, and radiation dose during the pancreatic parenchymal phase: effect of a low-tube-voltage, high-tube-current CT technique--preliminary results. Radiology. 2010;256(2):450–9. https://doi.org/10.1148/radiol.10091819.

    Article  PubMed  Google Scholar 

  26. Lee SH, Lee JM, Kim KW, Klotz E, Kim SH, Lee JY, et al. Dual-energy computed tomography to assess tumor response to hepatic radiofrequency ablation: potential diagnostic value of virtual noncontrast images and iodine maps. Investig Radiol. 2011;46(2):77–84. https://doi.org/10.1097/RLI.0b013e3181f23fcd.

    Article  Google Scholar 

  27. Fischer MA, Kartalis N, Grigoriadis A, Loizou L, Stal P, Leidner B, et al. Perfusion computed tomography for detection of hepatocellular carcinoma in patients with liver cirrhosis. Eur Radiol. 2015;25(11):3123–32. https://doi.org/10.1007/s00330-015-3732-1.

    Article  PubMed  Google Scholar 

  28. Wu D, Tan M, Zhou M, Sun H, Ji Y, Chen L, et al. Liver computed tomographic perfusion in the assessment of microvascular invasion in patients with small hepatocellular carcinoma. Investig Radiol. 2015;50(4):188–94. https://doi.org/10.1097/rli.0000000000000098.

    Article  Google Scholar 

  29. Hatzidakis A, Perisinakis K, Kalarakis G, Papadakis A, Savva E, Ippolito D, et al. Perfusion-CT analysis for assessment of hepatocellular carcinoma lesions: diagnostic value of different perfusion maps. Acta Radiol. 2019;60(5):561–8. https://doi.org/10.1177/0284185118791200.

    Article  PubMed  Google Scholar 

  30. Marquez HP, Puippe G, Mathew RP, Alkadhi H, Pfammatter T, Fischer MA. CT perfusion for early response evaluation of radiofrequency ablation of focal liver lesions: first experience. Cardiovasc Intervent Radiol. 2017;40(1):90–8. https://doi.org/10.1007/s00270-016-1444-9.

    Article  PubMed  Google Scholar 

  31. Kim KA, Choi SY, Kim MU, Baek SY, Park SH, Yoo K, et al. The efficacy of cone-beam CT-based liver perfusion mapping to predict initial response of hepatocellular carcinoma to transarterial chemoembolization. J Vasc Interv Radiol. 2019;30(3):358–69. https://doi.org/10.1016/j.jvir.2018.10.002.

    Article  PubMed  Google Scholar 

  32. Borgheresi A, Gonzalez-Aguirre A, Brown KT, Getrajdman GI, Erinjeri JP, Covey A, et al. Does enhancement or perfusion on preprocedure CT predict outcomes after embolization of hepatocellular carcinoma? Acad Radiol. 2018;25(12):1588–94. https://doi.org/10.1016/j.acra.2018.02.027.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Ippolito D, Querques G, Okolicsanyi S, Franzesi CT, Strazzabosco M, Sironi S. Diagnostic value of dynamic contrast-enhanced CT with perfusion imaging in the quantitative assessment of tumor response to sorafenib in patients with advanced hepatocellular carcinoma: a feasibility study. Eur J Radiol. 2017;90:34–41. https://doi.org/10.1016/j.ejrad.2017.02.027.

    Article  PubMed  Google Scholar 

  34. Ippolito D, Querques G, Okolicsanyi S, Talei Franzesi C, Pecorelli A, Lombardi S, et al. Dynamic contrast enhanced perfusion CT imaging: a diagnostic biomarker tool for survival prediction of tumour response to antiangiogenetic treatment in patients with advanced HCC lesions. Eur J Radiol. 2018;106:62–8. https://doi.org/10.1016/j.ejrad.2018.07.012.

    Article  PubMed  Google Scholar 

  35. Ippolito D, Querques G, Pecorelli A, Talei Franzesi C, Okolicsanyi S, Strazzabosco M, et al. Diagnostic value of quantitative perfusion computed tomography technique in the assessment of tumor response to sorafenib in patients with advanced hepatocellular carcinoma. J Comput Assist Tomogr. 2019;43(2):206–13. https://doi.org/10.1097/rct.0000000000000807.

    Article  PubMed  Google Scholar 

  36. Davnall F, Yip CS, Ljungqvist G, Selmi M, Ng F, Sanghera B, et al. Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice? Insights Imaging. 2012;3(6):573–89. https://doi.org/10.1007/s13244-012-0196-6.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Yang Z, Tang LH, Klimstra DS. Effect of tumor heterogeneity on the assessment of Ki67 labeling index in well-differentiated neuroendocrine tumors metastatic to the liver: implications for prognostic stratification. Am J Surg Pathol. 2011;35(6):853–60. https://doi.org/10.1097/PAS.0b013e31821a0696.

    Article  PubMed  Google Scholar 

  38. Raman SP, Schroeder JL, Huang P, Chen Y, Coquia SF, Kawamoto S, et al. Preliminary data using computed tomography texture analysis for the classification of hypervascular liver lesions: generation of a predictive model on the basis of quantitative spatial frequency measurements—a work in progress. J Comput Assist Tomogr. 2015;39(3):383–95. https://doi.org/10.1097/RCT.0000000000000217.

    Article  PubMed  Google Scholar 

  39. Li M, Fu S, Zhu Y, Liu Z, Chen S, Lu L, et al. Computed tomography texture analysis to facilitate therapeutic decision making in hepatocellular carcinoma. Oncotarget. 2016;7(11):13248. https://doi.org/10.18632/oncotarget.7467.

    Article  PubMed  PubMed Central  Google Scholar 

  40. • Mulé S, Thiefin G, Costentin C, Durot C, Rahmouni A, Luciani A, et al. Advanced hepatocellular carcinoma: pretreatment contrast-enhanced CT texture parameters as predictive biomarkers of survival in patients treated with sorafenib. Radiology. 2018;288(2):445–55. https://doi.org/10.1148/radiol.2018171320This study examined the value of pretreatment CT texture analysis in predicting the overall survival and time to progression in 92 patients with advanced HCC treated with sorafenib. Portal venous phase-derived entropy at fine, medium, and coarse texture scales have been identified as independent predictors of overall survival of these patients.

    Article  PubMed  Google Scholar 

  41. Fu S, Chen S, Liang C, Liu Z, Zhu Y, Li Y, et al. Texture analysis of intermediate-advanced hepatocellular carcinoma: prognosis and patients’ selection of transcatheter arterial chemoembolization and sorafenib. Oncotarget. 2017;8(23):37855. https://doi.org/10.18632/oncotarget.13675.

    Article  PubMed  Google Scholar 

  42. Letzen B, Wang CJ, Chapiro J. The role of artificial intelligence in interventional oncology: a primer. J Vasc Interv Radiol. 2019;30(1):38–41.e31. https://doi.org/10.1016/j.jvir.2018.08.032.

    Article  PubMed  Google Scholar 

  43. Yasaka K, Akai H, Kunimatsu A, Kiryu S, Abe O. Deep learning with convolutional neural network in radiology. Jpn J Radiol. 2018;36(4):257–72. https://doi.org/10.1007/s11604-018-0726-3.

    Article  PubMed  Google Scholar 

  44. Yasaka K, Abe O. Deep learning and artificial intelligence in radiology: current applications and future directions. PLoS Med. 2018;15(11):1002707. https://doi.org/10.1371/journal.pmed.1002707.

    Article  Google Scholar 

  45. •• Yasaka K, Akai H, Abe O, Kiryu S. Deep learning with convolutional neural network for differentiation of liver masses at dynamic contrast-enhanced CT: a preliminary study. Radiology. 2017;286(3):887–96. https://doi.org/10.1148/radiol.2017170706This research assessed the diagnostic performance of AI-based methods in characterization of liver tumors by studying CT image sets of 460 patients. Investigators demonstrated that deep learning could accurately differentiate liver lesions with an accuracy of 0.84.

    Article  PubMed  Google Scholar 

  46. Kutlu H, Avci E. A novel method for classifying liver and brain tumors using convolutional neural networks, discrete wavelet transform and long short-term memory networks. Sensors (Basel, Switzerland). 2019;19(9). https://doi.org/10.3390/s19091992.

    Article  Google Scholar 

  47. Mokrane FZ, Lu L, Vavasseur A, Otal P, Peron JM, Luk L, et al. Radiomics machine-learning signature for diagnosis of hepatocellular carcinoma in cirrhotic patients with indeterminate liver nodules. Eur Radiol. 2020;30(1):558–70. https://doi.org/10.1007/s00330-019-06347-w.

    Article  PubMed  Google Scholar 

  48. Wu CF, Wu YJ, Liang PC, Wu CH, Peng SF, Chiu HW. Disease-free survival assessment by artificial neural networks for hepatocellular carcinoma patients after radiofrequency ablation. J Formos Med Assoc. 2017;116(10):765–73. https://doi.org/10.1016/j.jfma.2016.12.006.

    Article  PubMed  Google Scholar 

  49. Kambadakone AR, Fung A, Gupta RT, Hope TA, Fowler KJ, Lyshchik A, et al. LI-RADS technical requirements for CT, MRI, and contrast-enhanced ultrasound. Abdom Radiol (NY). 2018;43(1):56–74. https://doi.org/10.1007/s00261-017-1325-y.

    Article  PubMed  Google Scholar 

  50. Kaur H, Hindman NM, Al-Refaie WB, Arif-Tiwari H, Cash BD, Chernyak V, et al. ACR appropriateness criteria suspected liver metastases. JJ Am Coll Radiol. 2017;14(5s):314–25. https://doi.org/10.1016/j.jacr.2017.01.037.

    Article  Google Scholar 

  51. Wei C, Tan J, Xu L, Juan L, Zhang SW, Wang L, et al. Differential diagnosis between hepatic metastases and benign focal lesions using DWI with parallel acquisition technique: a meta-analysis. Tumour Biol. 2015;36(2):983–90. https://doi.org/10.1007/s13277-014-2663-9.

    Article  CAS  PubMed  Google Scholar 

  52. Chen J, Wu M, Liu R, Li S, Gao R, Song B. Preoperative evaluation of the histological grade of hepatocellular carcinoma with diffusion-weighted imaging: a meta-analysis. PLoS One. 2015;10(2):e0117661. https://doi.org/10.1371/journal.pone.0117661.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Shankar S, Kalra N, Bhatia A, Srinivasan R, Singh P, Dhiman RK, et al. Role of diffusion weighted imaging (DWI) for hepatocellular carcinoma (HCC) detection and its grading on 3T MRI: a prospective study. J Clin Exp Hepatol. 2016;6(4):303–10. https://doi.org/10.1016/j.jceh.2016.08.012.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Li X, Li C, Wang R, Ren J, Yang J, Zhang Y. Combined application of gadoxetic acid disodium-enhanced magnetic resonance imaging (MRI) and diffusion-weighted imaging (DWI) in the diagnosis of chronic liver disease-induced hepatocellular carcinoma: a meta-analysis. PLoS One. 2015;10(12):0144247. https://doi.org/10.1371/journal.pone.0144247.

    Article  CAS  Google Scholar 

  55. Taron J, Johannink J, Bitzer M, Nikolaou K, Notohamiprodjo M, Hoffmann R. Added value of diffusion-weighted imaging in hepatic tumors and its impact on patient management. Cancer Imaging. 2018;18(1):10. https://doi.org/10.1186/s40644-018-0140-1.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Colagrande S, Castellani A, Nardi C, Lorini C, Calistri L, Filippone A. The role of diffusion-weighted imaging in the detection of hepatic metastases from colorectal cancer: a comparison with unenhanced and Gd-EOB-DTPA enhanced MRI. Eur J Radiol. 2016;85(5):1027–34. https://doi.org/10.1016/j.ejrad.2016.02.011.

    Article  PubMed  Google Scholar 

  57. Vilgrain V, Esvan M, Ronot M, Caumont-Prim A, Aube C, Chatellier G. A meta-analysis of diffusion-weighted and gadoxetic acid-enhanced MR imaging for the detection of liver metastases. Eur Radiol. 2016;26(12):4595–615. https://doi.org/10.1007/s00330-016-4250-5.

    Article  PubMed  Google Scholar 

  58. Kim SS, Kim SH, Song KD, Choi SY, Heo NH. Value of gadoxetic acid-enhanced MRI and diffusion-weighted imaging in the differentiation of hypervascular hyperplastic nodule from small (<3 cm) hypervascular hepatocellular carcinoma in patients with alcoholic liver cirrhosis: a retrospective case-control study. J Magn Reson Imaging. 2019. https://doi.org/10.1002/jmri.26768.

    Article  Google Scholar 

  59. Lewis HL, Ghasabeh MA, Khoshpouri P, Kamel IR, Pawlik TM. Functional hepatic imaging as a biomarker of primary and secondary tumor response to loco-regional therapies. Surg Oncol. 2017;26(4):411–22. https://doi.org/10.1016/j.suronc.2017.08.004.

    Article  CAS  PubMed  Google Scholar 

  60. Alis D, Durmaz ESM, Gulsen F, Bas A, Kabasakal L, Sager S, et al. Prognostic value of ADC measurements in predicting overall survival in patients undergoing (90)Y radioembolization for colorectal cancer liver metastases. Clin Imaging. 2019;57:124–30. https://doi.org/10.1016/j.clinimag.2019.05.015.

    Article  PubMed  Google Scholar 

  61. Labeur TA, Runge JH, Klompenhouwer EG, Klumpen HJ, Takkenberg RB, van Delden OM. Diffusion-weighted imaging of hepatocellular carcinoma before and after transarterial chemoembolization: role in survival prediction and response evaluation. Abdom Radiol (NY). 2019;44(8):2740–50. https://doi.org/10.1007/s00261-019-02030-2.

    Article  Google Scholar 

  62. Semaan S, Makkar J, Lewis S, Chatterji M, Kim E, Taouli B. Imaging of hepatocellular carcinoma response after (90)Y radioembolization. AJR Am J Roentgenol. 2017;209(5):W263–w276. https://doi.org/10.2214/ajr.17.17993.

    Article  PubMed  Google Scholar 

  63. Schmeel FC, Simon B, Luetkens JA, Traber F, Meyer C, Schmeel LC, et al. Prognostic value of pretreatment diffusion-weighted magnetic resonance imaging for outcome prediction of colorectal cancer liver metastases undergoing 90Y-microsphere radioembolization. J Cancer Res Clin Oncol. 2017;143(8):1531–41. https://doi.org/10.1007/s00432-017-2395-5.

    Article  CAS  PubMed  Google Scholar 

  64. • Wu L, Xu P, Rao S, Yang L, Chen C, Liu H, et al. ADC total ratio and D ratio derived from intravoxel incoherent motion early after TACE are independent predictors for survival in hepatocellular carcinoma. J Magn Reson Imaging. 2017;46(3):820–30. https://doi.org/10.1002/jmri.25617This study reported the value of IVIM-DWI parameters in predicting treatment responses and overall survival in 30 patients with unresectable HCC patients who underwent TACE. Authors showed that ADC andDvalues were independent predictors of treatment responses and overall survival.

    Article  PubMed  Google Scholar 

  65. Wu H, Liang Y, Jiang X, Wei X, Liu Y, Liu W, et al. Meta-analysis of intravoxel incoherent motion magnetic resonance imaging in differentiating focal lesions of the liver. Medicine (Baltimore). 2018;97(34):e12071. https://doi.org/10.1097/md.0000000000012071.

    Article  Google Scholar 

  66. Zhu SC, Liu YH, Wei Y, Li LL, Dou SW, Sun TY, et al. Intravoxel incoherent motion diffusion-weighted magnetic resonance imaging for predicting histological grade of hepatocellular carcinoma: comparison with conventional diffusion-weighted imaging. World J Gastroenterol. 2018;24(8):929–40. https://doi.org/10.3748/wjg.v24.i8.929.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Granata V, Fusco R, Catalano O, Guarino B, Granata F, Tatangelo F, et al. Intravoxel incoherent motion (IVIM) in diffusion-weighted imaging (DWI) for hepatocellular carcinoma: correlation with histologic grade. Oncotarget. 2016;7(48):79357–64. https://doi.org/10.18632/oncotarget.12689.

    Article  PubMed  PubMed Central  Google Scholar 

  68. Andreou A, Koh DM, Collins DJ, Blackledge M, Wallace T, Leach MO, et al. Measurement reproducibility of perfusion fraction and pseudodiffusion coefficient derived by intravoxel incoherent motion diffusion-weighted MR imaging in normal liver and metastases. Eur Radiol. 2013;23(2):428–34. https://doi.org/10.1007/s00330-012-2604-1.

    Article  CAS  PubMed  Google Scholar 

  69. Kim SY, Lee SS, Park B, Kim N, Kim JK, Park SH, et al. Reproducibility of measurement of apparent diffusion coefficients of malignant hepatic tumors: effect of DWI techniques and calculation methods. J Magn Reson Imaging. 2012;36(5):1131–8. https://doi.org/10.1002/jmri.23744.

    Article  PubMed  Google Scholar 

  70. Orton MR, Collins DJ, Koh DM, Leach MO. Improved intravoxel incoherent motion analysis of diffusion weighted imaging by data driven Bayesian modeling. Magn Reson Med. 2014;71(1):411–20. https://doi.org/10.1002/mrm.24649.

    Article  PubMed  Google Scholar 

  71. Mathew RP, Venkatesh SK. Imaging of hepatic fibrosis. Curr Gastroenterol Rep. 2018;20(10):45–10. https://doi.org/10.1007/s11894-018-0652-7.

    Article  PubMed  Google Scholar 

  72. Jiang H, Zheng T, Duan T, Chen J, Song B. Non-invasive in vivo imaging grading of liver fibrosis. J Clin Transl Hepatol. 2018;6(2):198–207. https://doi.org/10.14218/jcth.2017.00038.

    Article  PubMed  PubMed Central  Google Scholar 

  73. Thompson SM, Wang J, Chandan VS, Glaser KJ, Roberts LR, Ehman RL, et al. MR elastography of hepatocellular carcinoma: correlation of tumor stiffness with histopathology features—preliminary findings. Magn Reson Imaging. 2017;37:41–5. https://doi.org/10.1016/j.mri.2016.11.005.

    Article  PubMed  Google Scholar 

  74. Gordic S, Ayache JB, Kennedy P, Besa C, Wagner M, Bane O, et al. Value of tumor stiffness measured with MR elastography for assessment of response of hepatocellular carcinoma to locoregional therapy. Abdom Radiol (NY). 2017;42(6):1685–94. https://doi.org/10.1007/s00261-017-1066-y.

    Article  PubMed  PubMed Central  Google Scholar 

  75. Motosugi U, Ichikawa T, Koshiishi T, Sano K, Morisaka H, Ichikawa S, et al. Liver stiffness measured by magnetic resonance elastography as a risk factor for hepatocellular carcinoma: a preliminary case–control study. Eur Radiol. 2013;23(1):156–62. https://doi.org/10.1007/s00330-012-2571-6.

    Article  PubMed  Google Scholar 

  76. • Wang J, Shan Q, Liu Y, Yang H, Kuang S, He B, et al. 3D MR elastography of hepatocellular carcinomas as a potential biomarker for predicting tumor recurrence. J Magn Reson Imaging. 2019;49(3):719–30. https://doi.org/10.1002/jmri.26250This research highlighted the role of 3D MRE measures as a significant biomarker that can predict the early recurrence of HCC within 2 years after resection by studying 99 patients; each peak kilovoltage increase in MRE tumor stiffness was associated with a 16.3% increased risk of HCC recurrence.

    Article  PubMed  Google Scholar 

  77. Jang S, Lee JM, Lee DH, Joo I, Yoon JH, Chang W, et al. Value of MR elastography for the preoperative estimation of liver regeneration capacity in patients with hepatocellular carcinoma. J Magn Reson Imaging. 2017;45(6):1627–36. https://doi.org/10.1002/jmri.25517.

    Article  PubMed  Google Scholar 

  78. Lee DH, Lee JM, Yi N-J, Lee K-W, Suh K-S, Lee J-H, et al. Hepatic stiffness measurement by using MR elastography: prognostic values after hepatic resection for hepatocellular carcinoma. Eur Radiol. 2017;27(4):1713–21. https://doi.org/10.1007/s00330-016-4499-8.

    Article  PubMed  Google Scholar 

  79. Kamimura K, Fukukura Y, Yoneyama T, Takumi K, Tateyama A, Umanodan A, et al. Quantitative evaluation of liver function with T1 relaxation time index on Gd-EOB-DTPA-enhanced MRI: comparison with signal intensity-based indices. J Magn Reson Imaging. 2014;40(4):884–9. https://doi.org/10.1002/jmri.24443.

    Article  PubMed  Google Scholar 

  80. Ding Y, Rao SX, Chen C, Li R, Zeng MS. Assessing liver function in patients with HBV-related HCC: a comparison of T(1) mapping on Gd-EOB-DTPA-enhanced MR imaging with DWI. Eur Radiol. 2015;25(5):1392–8. https://doi.org/10.1007/s00330-014-3542-x.

    Article  PubMed  Google Scholar 

  81. Unal E, Akata D, Karcaaltincaba M. Liver function assessment by magnetic resonance imaging. Semin Ultrasound CT MR. 2016;37(6):549–60. https://doi.org/10.1053/j.sult.2016.08.006.

    Article  PubMed  Google Scholar 

  82. Chen CY, Chen J, Xia CC, Huang ZX, Song B. T1 mapping combined with Gd-EOB-DTPA-enhanced magnetic resonance imaging in predicting the pathologic grading of hepatocellular carcinoma. Journal of biological regulators and homeostatic agents. J Biol Regul Homeost Agents. 2017;31(4):1029–36.

    CAS  PubMed  Google Scholar 

  83. Wang WT, Zhu S, Ding Y, Yang L, Chen CZ, Ye QH, et al. T1 mapping on gadoxetic acid-enhanced MR imaging predicts recurrence of hepatocellular carcinoma after hepatectomy. Eur J Radiol. 2018;103:25–31. https://doi.org/10.1016/j.ejrad.2018.03.027.

    Article  PubMed  Google Scholar 

  84. Nakagawa M, Namimoto T, Shimizu K, Morita K, Sakamoto F, Oda S, et al. Measuring hepatic functional reserve using T1 mapping of Gd-EOB-DTPA enhanced 3T MR imaging: a preliminary study comparing with (99m)Tc GSA scintigraphy and signal intensity based parameters. Eur J Radiol. 2017;92:116–23. https://doi.org/10.1016/j.ejrad.2017.05.011.

    Article  PubMed  Google Scholar 

  85. Peng Z, Jiang M, Cai H, Chan T, Dong Z, Luo Y, et al. Gd-EOB-DTPA-enhanced magnetic resonance imaging combined with T1 mapping predicts the degree of differentiation in hepatocellular carcinoma. BMC Cancer. 2016;16:625. https://doi.org/10.1186/s12885-016-2607-4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  86. Zhou W, Zhang L, Wang K, Chen S, Wang G, Liu Z, et al. Malignancy characterization of hepatocellular carcinomas based on texture analysis of contrast-enhanced MR images. J Magn Reson Imaging. 2017;45(5):1476–84. https://doi.org/10.1002/jmri.25454.

    Article  PubMed  Google Scholar 

  87. Li Z, Mao Y, Huang W, Li H, Zhu J, Li W, et al. Texture-based classification of different single liver lesion based on SPAIR T2W MRI images. BMC Med Imaging. 2017;17(1):42. https://doi.org/10.1186/s12880-017-0212-x.

    Article  PubMed  PubMed Central  Google Scholar 

  88. Hui TCH, Chuah TK, Low HM, Tan CH. Predicting early recurrence of hepatocellular carcinoma with texture analysis of preoperative MRI: a radiomics study. Clin Radiol. 2018;73(12):1011–56. https://doi.org/10.1016/j.crad.2018.07.109.

    Article  Google Scholar 

  89. Reimer RP, Reimer P, Mahnken AH. Assessment of therapy response to transarterial radioembolization for liver metastases by means of post-treatment MRI-based texture analysis. Cardiovasc Intervent Radiol. 2018;41(10):1545–56. https://doi.org/10.1007/s00270-018-2004-2.

    Article  PubMed  Google Scholar 

  90. Yu JY, Zhang HP, Tang ZY, Zhou J, He XJ, Liu YY, et al. Value of texture analysis based on enhanced MRI for predicting an early therapeutic response to transcatheter arterial chemoembolisation combined with high-intensity focused ultrasound treatment in hepatocellular carcinoma. Clin Radiol. 2018;73(8):758.e759–18. https://doi.org/10.1016/j.crad.2018.04.013.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, 600 North Wolfe Street, Hal B164, Baltimore, MD, 21287, USA

    Arya Haj-Mirzaian, Ana Kadivar, Ihab R. Kamel & Atif Zaheer

Authors
  1. Arya Haj-Mirzaian
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ana Kadivar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ihab R. Kamel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Atif Zaheer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Atif Zaheer.

Ethics declarations

Conflict of Interest

Arya Haj-Mirzaian, Ana Kadivar, Ihab R. Kamel, and Atif Zaheer declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Gastrointestinal Cancers

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Haj-Mirzaian, A., Kadivar, A., Kamel, I.R. et al. Updates on Imaging of Liver Tumors. Curr Oncol Rep 22, 46 (2020). https://doi.org/10.1007/s11912-020-00907-w

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11912-020-00907-w

Keywords

Search

Navigation